IOBTIO Biotech, Inc.

Nasdaq iobiotech.com


$ 0.82 $ -0.08 (-8.43 %)    

Wednesday, 11-Sep-2024 15:59:53 EDT
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 0.815
$ 0.87
$ 0.82 x 210
-- x --
$ 0.80 - $ 0.87
$ 0.79 - $ 2.10
640,078
na
53.69M
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-05-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-14-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 12-17-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-maintains-overweight-on-io-biotech-maintains-10-price-target

Piper Sandler analyst Christopher Raymond maintains IO Biotech (NASDAQ:IOBT) with a Overweight and maintains $10 price target.

 morgan-stanley-maintains-overweight-on-io-biotech-lowers-price-target-to-4

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target fro...

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-12-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $12 price target.

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-12-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $12 price target.

 hc-wainwright--co-maintains-buy-on-io-biotech-raises-price-target-to-12

HC Wainwright & Co. analyst Emily Bodnar maintains IO Biotech (NASDAQ:IOBT) with a Buy and raises the price target from ...

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-8-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

 io-biotech-q4-eps-040-misses-039-estimate

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) ...

 top-5-health-care-stocks-that-may-crash-this-month

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

 io-biotech-announces-first-patient-dosed-in-phase-2-neoadjuvantadjuvant-solid-tumor-basket-trial

IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vac...

 why-anavex-life-sciences-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quart...

 io-biotech-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...

 io-biotech-q3-eps-043-beats-044-estimate

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.44) by...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION